Home > Reform > Healthcare reform and hepatitis C: A convergence of risk and opportunity

Healthcare reform and hepatitis C: A convergence of risk and opportunity

January 15th, 2014

By Javier Sanabria

Changes from the Patient Protection and Affordable Care Act (ACA) are dominating the healthcare landscape. These changes are very important for people infected with the hepatitis C virus (HCV). Last year there was an increased federal public health effort aimed at diagnosing people with HCV. Baby Boomers, the generation with the most HCV-infected people, has started to become eligible for Medicare.

Further, new treatments for HCV are under development. Undiagnosed individuals and uninsured individuals may represent a population that payors and stakeholders have not yet experienced. This paper discusses how increased diagnosis, increased Medicare eligibility, and newly insured individuals with HCV will affect the U.S. healthcare system.

Reform , , , ,

  1. January 15th, 2014 at 19:56 | #1

    I think this is an interesting area which, as described, is both a problem, as well as, an opportunity. However, I believe it is one of many areas and consequences of the ACA which I think make real cost and demand projections difficult until more is known. While not directly related to this area I think a stepped approach bringing in desired elements over time would have allowed for a more realistic and more manageable situation.

  1. No trackbacks yet.